mCRPC Clinical Trials in Amersfoort, Utrecht
2 recruitingAmersfoort, Utrecht, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Pfizer600 enrolled233 locationsNCT06551324
Recruiting
Not Applicable
The Radium-select Study
Male Urogenital DiseasesmCRPC
The Netherlands Cancer Institute60 enrolled5 locationsNCT06659926